COMMUNIQUÉS West-GlobeNewswire

TRACON Pharmaceuticals Appoints Biotech Industry Veteran Mark Wiggins as Chief Business Officer
30/05/2018
Mr. Wiggins Brings Over 30 Years of Business Development and Commercial Experience in Biotech to TRACON SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a biopharmaceutical company [...]
Tonix Pharmaceuticals to Present at the 2018 BIO International Convention
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present an overview [...]
Allena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
30/05/2018
NEWTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme [...]
Humanigen CEO to Present at 8th Annual LD Micro Invitational
30/05/2018
BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company developing cutting-edge T-cell optimization and oncology treatments, today announced that Cameron Durrant, M [...]
Ovid Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference on June 8, 2018
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
BioSyent Releases Results for Q1 2018
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three months ended March 31, 2018. Key highlights include: First quarter ( [...]
K2M Receives FDA Clearance for BACS® Patient-Specific Module
30/05/2018
Surgeon-tailored rods, rails, and templates to treat spinal deformity LEESBURG, Va., May 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine [...]
ContraVir Pharmaceuticals’ Cyclophilin Inhibitor, CRV431, Reduces Development and Progression of Liver Tumors in Preclinical Hepatocellular Carcinoma Study
30/05/2018
EDISON, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Spectral Provides Corporate Update
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT ), a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
BURLINGTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
30/05/2018
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
PolarityTE to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
SALT LAKE CITY, May 30, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (Nasdaq: COOL ) today announced it will present at the Jefferies 2018 Global Healthcare Conference on Thursday, June 7, 2018 at 2:30pm ET. Denver M. [...]
Selecta Biosciences to Present at the Jefferies Global Healthcare Conference on June 06, 2018
30/05/2018
WATERTOWN, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
BeyondSpring Announces $20 Million Registered Direct Offering
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ) (“BeyondSpring”), a global, clinical-stage biopharmaceutical company focused on the development and commercialization of innovative cancer [...]
Bellicum Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
HOUSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering ESKATA
30/05/2018
Issuance of U.S. Patent No. 9,980,983 Further Strengthens Aclaris’ ESKATA™ Patent Portfolio WAYNE, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical [...]
Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer
30/05/2018
BOSTON, May 30, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company using its proprietary knowledge of MetAP2 systems biology to help patients affected by a range of [...]
Antares Pharma Announces Receipt of Third Installment From Sale of ZOMAJET™ Needle-Free Delivery System
30/05/2018
EWING, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) (“Antares”) (“The Company”) today announced that it has received $4.75 million from Ferring Pharmaceuticals (“Ferring”) in connection [...]
ContraFect to Present New Data on CF-301 (exebacase) and Lysins Targeting Gram-Negative Pathogens at ASM Microbe 2018
30/05/2018
YONKERS, N.Y., May 30, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX ), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]

Pages